MEDIA TIP SHEET: Colorado State University experts can discuss Ebola

Colorado State University has several experts who can talk with reporters about the Ebola outbreak.

CSU does not work with the Ebola virus. The university does not have a Biosafety Level 4 facility, the highest safety level, which is required for research with Ebola and other highly dangerous pathogens.

Yet CSU has substantial expertise in infectious diseases; its researchers can discuss history of Ebola, its characteristics, how it spreads, biosafety procedures and biocontainment.

These researchers, and their areas of expertise, include:

• Charles Calisher, professor emeritus of microbiology, immunology and pathology and author of “Lifting the Impenetrable Veil: From Yellow Fever to Ebola Hemorrhagic Fever and SARS,” can discuss the history of Ebola and its characteristics.

• Bob Ellis, CSU biosafety officer and professor of microbiology, immunology and pathology, can discuss biosafety procedures and biocontainment – the methods used for handling, researching and safely containing viruses, bacteria and other pathogens that cause infectious disease.

• Rick Lyons, director of CSU’s Infectious Disease Research Center (, can discuss how Ebola spreads and therapies under development. The center he directs houses about 50,000 square feet of Biosafety Level 2 and Biosafety Level 3 laboratory space; its researchers focus on well-known and emerging infectious diseases.

• Alan Rudolph, CSU vice president for research, can discuss Ebola as a threat to defending the U.S., public health and safety. Before joining CSU to lead its research enterprise about a year ago, Rudolph was director of biological and chemical technologies for the U.S. Department of Defense/Department of Homeland Security. In this role, he was responsible for overseeing $500 million a year in research and development against select agents and biological and chemical threats.

To schedule an interview, contact Jeff Dodge at (970) 491-4251 or